
HLS Therapeutics Hits Day Low of CAD 4.51 Amid Price Pressure
2025-11-14 16:46:07HLS Therapeutics, Inc. faced a notable stock decline today, reflecting ongoing market challenges. Over the past week and month, the company has seen significant decreases, contrasting with positive performance in the S&P/TSX 60 index. Long-term metrics reveal substantial declines and financial difficulties, including a high Debt to EBITDA ratio.
Read MoreNo announcement available
Corporate Actions
No corporate action available






